[Evaluation of the efficacy and tolerance of betamethasone dipropionate and salicylic acid in steroid-sensitive dry dermatosis].
D001623:Betamethasone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D012459:Salicylates / Q000627:therapeutic use*; D020156:Salicylic Acid
D012459:Salicylates; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone; D020156:Salicylic Acid
Studio per la valutazione dell'efficacia e tollerabilità di betametasone dipropionato e acido salicilico nelle dermatosi secche steroido-sensibili.